Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00441532 · ClinicalTrials.gov registry record · NA
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00441532 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 50 participants.
The verdict
NCT00441532, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Patients at risk for having prostate cancer usually undergo a biopsy of their prostate. This is most often done in the private urology office. Recent studies have suggested that injection of local anesthesia (lidocaine) near the nerves of the prostate will improve pain sensation during the biopsy procedure. Local anesthesia can be given through a separate needle through the rectal probe just prior to biopsy. However, many urologists to date perform their biopsies without anesthesia. Some claim that the needle used for anesthesia causes pain itself. Others claim that the pain is so minimal that the additional use of lidocaine (and extra time) is not necessary. We plan to reexamine the use of lidocaine and perform the first study where each patient will receive lidocaine and placebo on separate sides of their prostate.
Interventions
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00441532
The ClinicalTrials.gov registry entry for NCT00441532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.
NCT00441532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00441532 about?
NCT00441532 is a clinical study titled "Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy". Patients at risk for having prostate cancer usually undergo a biopsy of their prostate. This is most often done in the private urology office. Recent studies have suggested that injection of local anesthesia (lidocaine) near the nerves of the prostate will improve pain sensation during the biopsy pr...
What is the current status of trial NCT00441532?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2005-08. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00441532?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT00441532?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.